Behalf fills a significant economic need, by offering access to short-term financing for businesses of all size, with flexible repayment terms. Our innovative method of analyzing credit requires businesses to answer just four questions. Then, they get access to fast, fair financing to help them seize opportunities, address cash flow needs, and keep growing. We pay vendors directly, so there’s no paperwork to deal with, no time wasted waiting for checks to clear, making the process as simple and efficient as possible.
Type
Private
HQ
New York, US
Founded
2011
Size (employees)
107 (est)+3%
Website
behalf.com
Behalf was founded in 2011 and is headquartered in New York, US
Report incorrect company information

Key People/Management at Behalf

Osher Frimerman

Osher Frimerman

CTO

Behalf Office Locations

Behalf has an office in New York
New York, US (HQ)
3 W 18th St
Show all (1)
Report incorrect company information

Behalf Financials and Metrics

Summary Metrics

Founding Date

2011

Total Funding

$166 m

Latest funding size

$27 m

Time since last funding

2 years ago

Investors

Behalf's latest funding round in August 2016 was reported to be $27 m. In total, Behalf has raised $166 m
Show all financial metrics
Report incorrect company information

Behalf Online and Social Media Presence

Embed Graph
Report incorrect company information

Behalf News and Updates

Former White House Special Counsel Lanny Davis to Hold Telephonic Press Conference on Behalf of Dr. Carlos Beharie Challenging Hospital for Hostile Actions That Caused the Destruction of Dr. Beharie's OB/GYN Practice in Southern California

LOS ANGELES, June 19, 2018 /PRNewswire/ -- WHAT:    Press conference to challenge a Los Angeles area hospital and its affiliates for their hostile actions against Citrus Obstetrics & Gynecology Medical Associates, formerly the OB/GYN practice of Dr. Carlos Beharie, that l...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valeant Pharmaceuticals International, Inc. - VRX

NEW YORK, June 19, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Valeant Pharmaceuticals International, Inc. ("Valeant" or the "Company") (NYSE: VRX).   Such investors are advised to contact Robert S. Willoughby at rswilloughby@po...

Shrader and Associates LLP: Ploetz Lawyers Respond to NCAA

HOUSTON, June 18, 2018 /PRNewswire/ -- The following is a statement from Justin Shrader, Shrader and Associates LLP: We were dismayed to read the press release from the NCAA issued on June 15th.  Friday marked a day that the NCAA could have reset the conversation on CTE and repetitive...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Catalyst Biosciences, Inc. - CBIO

NEW YORK, June 18, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Catalyst Biosciences, Inc. ("Catalyst" or the "Company") (NASDAQ: CBIO).   Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529...

Faruqi & Faruqi, LLP is Investigating Intersect ENT, Inc. (XENT) on Behalf of its Shareholders

NEW YORK, June 18, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential breaches of fiduciary duty by the board of directors at Intersect ENT, Inc. ("Intersect" or the "Company") (NASDAQ: XENT). Request more information now...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ANTA Sports Products Limited - ANPDY

NEW YORK, June 15, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ANTA Sports Products Limited ("ANTA" or the "Company") (OTC MKT: ANPDY).   Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529...
Show more
Report incorrect company information